GALE Stock Overview
Operates as a healthcare service provider in Switzerland and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Galenica AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CHF 74.25 |
52 Week High | CHF 78.15 |
52 Week Low | CHF 65.10 |
Beta | 0.19 |
11 Month Change | 1.85% |
3 Month Change | 1.02% |
1 Year Change | 6.68% |
33 Year Change | 4.21% |
5 Year Change | 32.83% |
Change since IPO | 72.67% |
Recent News & Updates
Galenica (VTX:GALE) Might Have The Makings Of A Multi-Bagger
Sep 17Earnings Not Telling The Story For Galenica AG (VTX:GALE)
Jul 31Is Galenica (VTX:GALE) Using Too Much Debt?
Jun 16Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected
Apr 25Recent updates
Galenica (VTX:GALE) Might Have The Makings Of A Multi-Bagger
Sep 17Earnings Not Telling The Story For Galenica AG (VTX:GALE)
Jul 31Is Galenica (VTX:GALE) Using Too Much Debt?
Jun 16Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected
Apr 25We Think The Compensation For Galenica AG's (VTX:GALE) CEO Looks About Right
Apr 04Slowing Rates Of Return At Galenica (VTX:GALE) Leave Little Room For Excitement
Mar 29Pinning Down Galenica AG's (VTX:GALE) P/E Is Difficult Right Now
Jan 22Is There An Opportunity With Galenica AG's (VTX:GALE) 42% Undervaluation?
Jan 04Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Oct 26Is Galenica (VTX:GALE) Using Too Much Debt?
Oct 11Are Investors Undervaluing Galenica AG (VTX:GALE) By 42%?
Sep 26These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Jun 20Here's What To Make Of Galenica's (VTX:GALE) Decelerating Rates Of Return
Apr 17We Think Galenica (VTX:GALE) Can Stay On Top Of Its Debt
Mar 12Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Jan 08These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Nov 28The Returns At Galenica (VTX:GALE) Aren't Growing
Sep 20Is Galenica (VTX:GALE) A Risky Investment?
Aug 30Return Trends At Galenica (VTX:GALE) Aren't Appealing
Jun 15Galenica (VTX:GALE) Could Easily Take On More Debt
Apr 06Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Feb 15Should You Be Adding Galenica (VTX:GALE) To Your Watchlist Today?
Jan 02Does Galenica (VTX:GALE) Have A Healthy Balance Sheet?
Nov 30Returns At Galenica (VTX:GALE) Appear To Be Weighed Down
Oct 24With EPS Growth And More, Galenica (VTX:GALE) Is Interesting
Sep 25Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Aug 24Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Jul 24If You Like EPS Growth Then Check Out Galenica (VTX:GALE) Before It's Too Late
Jun 12Investors Met With Slowing Returns on Capital At Galenica (VTX:GALE)
Apr 07Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Mar 25Galenica AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 11Is Galenica AG (VTX:GALE) The Right Choice For A Smart Dividend Investor?
Feb 27Are Institutions Heavily Invested In Galenica AG's (VTX:GALE) Shares?
Jan 31Galenica (VTX:GALE) Shareholders Have Enjoyed A 25% Share Price Gain
Jan 13Is Galenica (VTX:GALE) Likely To Turn Things Around?
Dec 25Is Galenica (VTX:GALE) A Risky Investment?
Dec 09Is Galenica AG (VTX:GALE) An Attractive Dividend Stock?
Nov 24Shareholder Returns
GALE | CH Healthcare | CH Market | |
---|---|---|---|
7D | -1.2% | 0.3% | 0.2% |
1Y | 6.7% | 1.5% | 5.4% |
Return vs Industry: GALE exceeded the Swiss Healthcare industry which returned 2.4% over the past year.
Return vs Market: GALE exceeded the Swiss Market which returned 4.8% over the past year.
Price Volatility
GALE volatility | |
---|---|
GALE Average Weekly Movement | 2.0% |
Healthcare Industry Average Movement | 4.4% |
Market Average Movement | 3.4% |
10% most volatile stocks in CH Market | 7.3% |
10% least volatile stocks in CH Market | 1.5% |
Stable Share Price: GALE has not had significant price volatility in the past 3 months.
Volatility Over Time: GALE's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1927 | 7,955 | Marc Werner | www.galenica.com |
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands.
Galenica AG Fundamentals Summary
GALE fundamental statistics | |
---|---|
Market cap | CHF 3.70b |
Earnings (TTM) | CHF 169.68m |
Revenue (TTM) | CHF 3.80b |
21.8x
P/E Ratio1.0x
P/S RatioIs GALE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GALE income statement (TTM) | |
---|---|
Revenue | CHF 3.80b |
Cost of Revenue | CHF 3.34b |
Gross Profit | CHF 464.58m |
Other Expenses | CHF 294.90m |
Earnings | CHF 169.68m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 11, 2025
Earnings per share (EPS) | 3.41 |
Gross Margin | 12.22% |
Net Profit Margin | 4.46% |
Debt/Equity Ratio | 42.9% |
How did GALE perform over the long term?
See historical performance and comparison